familial amyloid cardiomyopathy
GPTKB entity
Statements (60)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Cardiology
|
| gptkbp:associated_with |
gptkb:depression
anxiety dizziness fatigue sleep disturbances weight loss vision problems chest pain hearing loss exercise intolerance syncope peripheral neuropathy carpal tunnel syndrome increased risk of heart attack cognitive impairment palpitations skin changes swelling in legs autonomic neuropathy kidney dysfunction gastrointestinal issues increased risk of stroke orthostatic hypotension systemic amyloidosis hereditary transthyretin amyloidosis increased risk of arrhythmias increased risk of heart failure increased risk of sudden cardiac death |
| gptkbp:caused_by |
amyloid protein deposition
|
| gptkbp:complication |
cardiac arrest
sudden cardiac death thromboembolism congestive heart failure ventricular hypertrophy |
| gptkbp:diagnosis |
blood tests
genetic testing biopsy echocardiogram cardiac MRI |
| gptkbp:genetic_studies |
TTR gene mutation
|
| https://www.w3.org/2000/01/rdf-schema#label |
familial amyloid cardiomyopathy
|
| gptkbp:premiered_on |
adulthood
|
| gptkbp:prevalence |
rare
|
| gptkbp:research_areas |
gptkb:Genetics
cardiology neurology pathology |
| gptkbp:risk_factor |
age
family history gender |
| gptkbp:symptoms |
heart failure
arrhythmias shortness of breath |
| gptkbp:treatment |
medications
supportive care lifestyle changes heart transplant |
| gptkbp:bfsParent |
gptkb:Transthyretin_amyloidosis
|
| gptkbp:bfsLayer |
6
|